Cargando…
Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
BACKGROUND: There is a lack of mechanism-driven, clinically relevant biomarkers in chronic obstructive pulmonary disease (COPD). Mitochondrial dysfunction, a proposed disease mechanism in COPD, is associated with the release of mitochondrial DNA (mtDNA), but plasma cell-free mtDNA has not been previ...
Autores principales: | Zhang, William Z., Hoffman, Katherine L., Schiffer, Kristen T., Oromendia, Clara, Rice, Michelle C., Barjaktarevic, Igor, Peters, Stephen P., Putcha, Nirupama, Bowler, Russell P., Wells, J. Michael, Couper, David J., Labaki, Wassim W., Curtis, Jeffrey L., Han, Meilan K., Paine, Robert, Woodruff, Prescott G., Criner, Gerard J., Hansel, Nadia N., Diaz, Ivan, Ballman, Karla V., Nakahira, Kiichi, Choi, Mary E., Martinez, Fernando J., Choi, Augustine M. K., Cloonan, Suzanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074408/ https://www.ncbi.nlm.nih.gov/pubmed/33902556 http://dx.doi.org/10.1186/s12931-021-01707-x |
Ejemplares similares
-
Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
por: Zhang, William Z., et al.
Publicado: (2020) -
Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018) -
Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017) -
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018) -
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
por: Labaki, Wassim W., et al.
Publicado: (2019)